Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases.
Ontology highlight
ABSTRACT: Randomized controlled trials have failed to report any survival advantage for WBRT combined with SRS in the management of brain metastases, despite the enhanced local and distant control in comparison to each treatment alone. Literature review have revealed important role of primary histology of the tumor when dealing with brain metastases. NSCLC responds better to combined approach even when there was only single brain metastasis present while breast cancer has registered better survival with SRS alone probably due to better response of primary tumor to advancement in surgical and chemotherapeutic agents. Furthermore, mutation status (EGFR/ALK) in lung cancer and receptor status (ER/PR/HER2) in breast cancer also exhibit diversity in their response to radiotherapy. Radioresistant tumors l
SUBMITTER: Khan M
PROVIDER: S-EPMC7358601 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA